Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations
Open Access
- 1 December 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 90 (3) , 517-521
- https://doi.org/10.1111/j.1365-2249.1992.tb05876.x
Abstract
Low plasma concentration of mannan binding protein (MBP) has been shown to be the basis for a common opsonic deficiency and suggested to be caused by a single nucleotide substitution at base 230 of exon 1 in the MBP gene. This substitution causes a replacement of glycine (codon GGC) with aspartic acid (codon GAC). Of 123 healthy Danish individuals investigated by polymerase chain reaction performed on exon 1, followed by restriction fragment length polymorphism or allospecific probing, 93 were homozygous (75.6%) for GGC, 28 heterozygous (22.8%), and two homozygous for GAC (1.6%). The gene frequency of the GAC allele was found to be 013. DNA sequencing of the cloned exon 1 from one GAC homozygous individual revealed no other substitution. The median MBP concentration in the group containing the GAC allele was 6.4 times lower than in the GGC homozygous group (195 and 1234 μ/l respectively). However, the range in plasma concentrations of MBP was wide and overlapping between the groups. MBP protein was detected in both the GAC homozygotes (9 and 387 μ/l. Furthermore, no difference in relative mass and biological activity (mannan binding) was found when sera containing the two forms of MBP were investigated. Accordingly, it can be concluded that the GAC allele is able to produce a functional MBP protein which may be detected in serum at low concentrations.Keywords
This publication has 11 references indexed in Scilit:
- The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase responseClinical and Experimental Immunology, 1992
- DEFICIENCY OF MANNAN BINDING PROTEIN-A NEW COMPLEMENT DEFICIENCY SYNDROMEClinical and Experimental Immunology, 1991
- Complement deficiency and diseaseImmunology Today, 1991
- Molecular basis of opsonic defect in immunodeficient childrenThe Lancet, 1991
- Functions and relevance of the terminal complement sequenceAnnals of Hematology, 1990
- ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATIONThe Lancet, 1989
- A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins.The Journal of Experimental Medicine, 1988
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Human class II major histocompatibility antigen β-chains are derived from at least three lociNature, 1983
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977